Used primarily as a key intermediate in pharmaceutical synthesis, especially in Suzuki-Miyaura cross-coupling reactions to form biaryl compounds. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients (APIs). The azetidine and pyrazole moieties contribute to structural diversity and improved pharmacokinetic properties in drug candidates, particularly in central nervous system and oncology-related therapies. It is also employed in medicinal chemistry research for building complex heterocyclic systems with enhanced metabolic stability.